Improving the immunogenicity of HIV-1 envelope trimer vaccines by Sanders Rogier W

HIV takes double hit before entry by Sanders Rogier W

Get full text

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41 by Caffrey Michael, Busser Els, Dankers Martijn M, Sanders Rogier W, Moore John P, Berkhout Ben

Get full text

A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells by Berkhout Ben, David Kathryn, van de Sandt Carolien, Bontjer Ilja, van Montfort Thijs, Eggink Dirk, de Vries Robert P, Matthews Katie, Melchers Mark, Moore John P, Sanders Rogier W

Get full text

The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion by Groot Fedde, Dankers Martijn M, Busser Els, Melchers Mark, Eggink Dirk, Bontjer Ilja, Liscaljet I Marije, Nabatov Alexei A, van Anken Eelco, Sanders Rogier W, Braakman Ineke, Berkhout Ben, Paxton William A

Get full text

Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination by Hu, Joyce K., Crampton, Jordan, Sanders, Rogier W., Moore, John P., Crotty, Shane, Tam, Hok Hei, Melo, Mariane Bandeira, Kang, Myung Sun, Pelet, Jeisa, Ruda, Vera, Foley, Maria Hottelet, Kumari, Sudha, Baldeon, Alexis D, Langer, Robert S, Anderson, Daniel Griffith, Chakraborty, Arup K, Irvine, Darrell J

Get full text
Get full text
Get full text
Get full text
Get full text
Get full text
Get full text

Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies by McCoy, Laura E., van Gils, Marit J., Ozorowski, Gabriel, Messmer, Terrence, Briney, Bryan, Voss, James E., Kulp, Daniel W., Macauley, Matthew S., Sok, Devin, Pauthner, Matthias, Menis, Sergey, Cottrell, Christopher A., Torres, Jonathan L., Hsueh, Jessica, Schief, William R., Wilson, Ian A., Ward, Andrew B., Sanders, Rogier W., Burton, Dennis R.

Get full text

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers by Pauthner, Matthias G., Nkolola, Joseph P., Havenar-Daughton, Colin, Murrell, Ben, Reiss, Samantha M., Bastidas, Raiza, Prévost, Jérémie, Nedellec, Rebecca, Bredow, Benjamin von, Abbink, Peter, Cottrell, Christopher A., Kulp, Daniel W. K, Tokatlian, Talar, Nogal, Bartek, Bianchi, Matteo, Li, Hui, Lee, Jeong Hyun, Butera, Salvatore T., Evans, David T., Hangartner, Lars, Finzi, Andrés, Wilson, Ian A., Wyatt, Richard T., Irvine, Darrell J., Irvine, Darrell J, Schief, William R., Ward, Andrew B., Sanders, Rogier W., Crotty, Shane, Shaw, George M., Barouch, Dan H., Burton, Dennis R.

Get full text